GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 Notes to the Consolidated Financial Statements for the year ended March 31, 2022 258 Ratio Numerator Denominator Mar-22 Mar-21 Variance Reason for variance 8 Net Capital Turnover Ratio Sale of Products Working Capital 1.77 4.75 -63% Mainly on account of cash received from sale of brands and other identified assets 9 Net Profit Ratio Profit after tax Revenue from operations 12% 17% -5% Mainly on account of tax adjustments of earlier years 10 Return on Capital Employed Profit before tax Net Worth 44% 36% 8% 11 Return on Investment Gain on Investment Total Investments 3% 5% -1% Due to reduction in fixed deposit rates Notes : (i) Ratios are calculated including profits from Discontinued operations but excludes the impact sale of brands and other identified assets and other exceptional items. (Refer Note 39 and 55). (ii) Return on Equity excluding impact of tax adjustments of prior years is 29.09%. (iii) Net Profit ratio excluding impact of tax adjustments of prior yearsis 17.02%. Note 57 : Consequent to the approval of the shareholders, the Parent on September 30, 2021, has acquired the assets and liabilities associated with the vaccine business of GlaxoSmithKline Asia Private Limited. The Parent Company has accounted the acquisition in accordance with Appendix C to IND AS 103 being business combination of entities under common control. Accordingly, the financial information in respect of prior periods has been restated for the acquisition as if the business combination has occurred from the beginning of preceding periods.The Parent Company has taken over the assets at amortised cost of ` 1,29.00 lakhs, liabilities taken over at ` 20,44.00 lakhs and the consideration paid amounts to ` 1,66.00 lakhs. The difference between the consideration paid and the net assets taken over on acquisition of ` 20,82.00 Lakhs has been transferred to Capital reserve. Note 58 : Relationship with struck off companies Below struck off companies are equity shareholders of the Company as on the Balance Sheet date Name of Struck off Company Nature of transaction with struck off company Gatisheel Finance Private Limited Shares held by struck off company Manilal Patel Private Limited Shares held by struck off company Haresh Extrusion Company Private Limited Shares held by struck off company K.S. Morarka and Sons Pvt. Ltd. Shares held by struck off company Sitaram Projects Private Limited Shares held by struck off company Siddha Papers Private Limited Shares held by struck off company Name of Struck off Company Nature of transaction Transaction during the year March 31, 2022 Balance outstanding as at March 31, 2022 Relationship with the struck off company Lanxess India Private Limited Trade Advance - 1.19 Vendor Vincon Infra Organisers Pvt. Ltd. Capital Advance - 2,83.17 Vendor Name of Struck off Company Nature of transaction Transaction during the year March 31, 2021 Balance outstanding as at March 31, 2021 Relationship with the struck off company Lanxess India Private Limited Trade Advance - 1.19 Vendor Vincon Infra Organisers Pvt. Ltd. Capital Advance - 2,83.17 Vendor